Q: Your opinion on Descartes please. It has fallen a lot and continues to do so. Is it time to bail, or is that just selling low? I also own CSU, MDA, OTC, ESL, AVO and a bit of GIB. I could switch DSG over to buy more GIB. Would this be a good switch?
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: Good morning team, Any reason you know of for the decline? Still a name you like? Thank you!
Q: After earnings release, stock opened higher then dropped a lot. What is your opinion on buy, hold or sell.
Thank you.
Thank you.
Q: Hi, Can you please provide some details and your comments on this company. The Chairman/CEO is perhaps a past Apple founder/executive and company seems to have a strong technology and a list of some highly reputed customers. This was one of the top picks on BNN on Wednesday and stock jumped almost 15%, Thursday on strong volume. Thanks
Q: What happened yesterday? Normal volatility?
Q: Are these the results that will finally stop the decline on this stock?
Q: Hi folks,can please get your opinion of rkn/t Q results,beat or miss,and would u rate stock buy,sell,hold. thx as always, jb
Q: Good morning Peter & all,
I would like your thoughts on SVC which I own (up 33%). How does the future look?
I would like your thoughts on SVC which I own (up 33%). How does the future look?
Q: Hello team,
In order to diversify the portfolio I am looking for some investments in biotech. Since Google recently declared the project for early cancer diagnostics based on nanotech I trust it could be fast growing area (risks are high of course...I understand). At the same time regardless of Google declarations (which might positively affect stock of nanotech companies) their stock behaves consistently bad. Three companies I took are just the example. So stock behavior varies from catastrophic with NSPH to just not good with BIND. Do you have any ideas - is it company related issue or it is trend which shows that market "doesn't believe"?
In order to diversify the portfolio I am looking for some investments in biotech. Since Google recently declared the project for early cancer diagnostics based on nanotech I trust it could be fast growing area (risks are high of course...I understand). At the same time regardless of Google declarations (which might positively affect stock of nanotech companies) their stock behaves consistently bad. Three companies I took are just the example. So stock behavior varies from catastrophic with NSPH to just not good with BIND. Do you have any ideas - is it company related issue or it is trend which shows that market "doesn't believe"?
Q: PETER,ALTHOUGH WIN PUT ITS SELF UP UNSUCESSFULLY FOR SALE A WHILE BACK,IS IT LIKELY IT COULD TRY AGAIN? YOU MENTIONED IT SHOULD PROBABLY GO PRIVATE,IF IT DID WHAT WOULD BE THE IMPLICATIONS FOR CURRENT SHAREHOLDERS? MANY THANX..JOHN
Q: Hi,
Your thoughts on Elon Musk's home rechargeable battery and it's investment impact on utility companies (Fortis, Emera, Canadian Utilities, etc…). I see Walmart is testing it out in some of their stores. I have read some pundits suggesting this will do to utility companies what the cell phone did to the land line business.
Thanks
Robert
Your thoughts on Elon Musk's home rechargeable battery and it's investment impact on utility companies (Fortis, Emera, Canadian Utilities, etc…). I see Walmart is testing it out in some of their stores. I have read some pundits suggesting this will do to utility companies what the cell phone did to the land line business.
Thanks
Robert
Q: hi, a large CDN firm has 23 cents and 79.6 million for consensus earnings for ago Q1/2015. thoughts
Q: Hello Peter et al,
Technology is under represented in our portfolio with CSU at 3.8% and OTC at 1.1%.
I would like to add one or two names, or one name plus add to OTC. Suggestions would be appreciated. The new holdings will be within a RIF but will be viewed as long term holds as there are other holdings that can be used for the annual withdrawal for the next few years.
Many thanks. Bob
Technology is under represented in our portfolio with CSU at 3.8% and OTC at 1.1%.
I would like to add one or two names, or one name plus add to OTC. Suggestions would be appreciated. The new holdings will be within a RIF but will be viewed as long term holds as there are other holdings that can be used for the annual withdrawal for the next few years.
Many thanks. Bob
Q: Hello Peter & team, Would you pls. comment on 2Q earnings. Would you still hold it? And if I may, what are your thoughts on QRVO...also good to keep holding?
Thank you!
Thank you!
Q: How does a small company with no money buy a billion dollar battery factory?
http://business.financialpost.com/news/energy/riding-teslas-coattails-this-tiny-ontario-battery-maker-just-bought-the-biggest-gigafactory-in-europe?__lsa=301e-fb0a
http://business.financialpost.com/news/energy/riding-teslas-coattails-this-tiny-ontario-battery-maker-just-bought-the-biggest-gigafactory-in-europe?__lsa=301e-fb0a
Q: Hi there,
I have been looking for an entry point for this technology player and am wondering if you think this is a good entry point. I show 25X this year's earnings - but it is off from its high and i have struggled with its valuation but the stock has always been pricey compared to its canadian counterparts. Do you think there is more downside here and a better entry point or worth stepping in now.
I have been looking for an entry point for this technology player and am wondering if you think this is a good entry point. I show 25X this year's earnings - but it is off from its high and i have struggled with its valuation but the stock has always been pricey compared to its canadian counterparts. Do you think there is more downside here and a better entry point or worth stepping in now.
Q: I would like to get you opinion on the recent press release detailing Orange's new product which is built off of Espial's HTML5 software solution.
No financial metrics were released but would this not be a potential game changer for ESP? I assume Orange is a significantly larger client than Espial's other clients that they have announced contracts with. Will Espial be seeing some revenue from this deal?
What do you think of the company in general?
Thanks
No financial metrics were released but would this not be a potential game changer for ESP? I assume Orange is a significantly larger client than Espial's other clients that they have announced contracts with. Will Espial be seeing some revenue from this deal?
What do you think of the company in general?
Thanks
Q: Good Day,
Would you please comment on MNW's March 2015 results and what are your outlooks going forward.
As always, great work guys.
HS
Would you please comment on MNW's March 2015 results and what are your outlooks going forward.
As always, great work guys.
HS
Q: Hi, Can you please comment on the earning announced after market, today. Looks like a nice beat on Adjusted EPS as well as Adjusted EBITDA numbers, despite revenue slightly below consensus? Also how is weak euro and strong US$ impacting the company, in your view? Thanks
Q: With the many downgrades today, and the stock down sharply after earnings, is it a good time to pick some or should I wait ? I guess the stock will not do much until the next quarter results and while the valuation is cheap and you are positive, there still might be a considerable downside to the stock price in the near term. I would like to avoid buying after the stock price has rebounded. Never too easy but what would you suggest? The fluctuations are in the range of 4-5% which is significant if I can get a feel for the trend over the next two weeks or so.
Regards
Regards